Prognostic and pharmacologic value of cystatin SN for chronic rhinosinusitis with nasal polyps

Di Wu,Bing Yan,Yang Wang,Chengshuo Wang,Luo Zhang
DOI: https://doi.org/10.1016/j.jaci.2021.01.036
IF: 14.29
2021-08-01
Journal of Allergy and Clinical Immunology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Integrated care pathways (ICPs) improve the management of patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The application of ICPs requires development of endotype-based biomarkers to stratify patients. The value of cytokines and markers induced by cytokines for the management of CRSwNP is largely unknown.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objectives</h3><p>To determine the prognostic and pharmacologic value of type 2, non-type 2 cytokines, and markers associated with type 2 inflammation including CCL26, periostin, and cystatin SN, in nasal secretions for CRSwNP.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>This retrospective study divided 151 patients with CRSwNP into discovery and validation phases. Concentrations of cytokines, CCL26, periostin, and cystatin SN in nasal secretions were determined using Luminex and ELISA. Predictive significance was assessed with receiver-operating characteristic curves. Survival analysis was performed using Kaplan-Meier curves and Cox regression models.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Cystatin SN was an independent predictor of the uncontrolled status of CRSwNP over a 2-year follow-up after adjusting for other risk factors (hazard ratio [HR] of 1.168 and 1.132 in discovery and validation phases, respectively; both <em>p</em> &lt; 0.001). Patients with high cystatin SN concentrations presented with a faster onset and higher rate of uncontrolled status than those with low levels (<em>p</em> &lt; 0.001). Enhanced medical treatment for patients with high cystatin SN levels postponed the uncontrolled status in discovery (<em>p</em> = 0.016) and validation phases (<em>p</em> = 0.002) but did not completely abolish it by the end of the follow-up.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Cystatin SN levels in nasal secretions hold strong prognostic value and can facilitate medical instructions for managing CRSwNP.</p>
immunology,allergy
What problem does this paper attempt to address?